A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study.

Choung, R S

A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study. [electronic resource] - Alimentary pharmacology & therapeutics Mar 2008 - 404-11 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1365-2036

10.1111/j.1365-2036.2007.03591.x doi


Adolescent
Adult
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Drug Tolerance
Electric Impedance
Female
Food
Gastroesophageal Reflux--physiopathology
Gastrointestinal Agents--adverse effects
Humans
Hydrogen-Ion Concentration
Male
Manometry
Middle Aged
Pyridines--adverse effects
Serotonin Receptor Agonists--adverse effects